The Effect of Oral Hyaluronic Acid (UltraHA®) on the Knee Function

Clinical Trial Description

In this study, the investigators will evaluate the knee condition before and after the intervention. The groups to be compared are two different doses of UltraHA® and a placebo. ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT02436577` - Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects	Phase 1
Active, not recruiting	`NCT05962008` - Effects of Consumption of Phosphatidylserine on the Cognitive Function	N/A
Completed	`NCT05803083` - The Effect of Oral Hyaluronic Acid on the Skin	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT02436577 - Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects

Phase 1

Active, not recruiting

NCT05962008 - Effects of Consumption of Phosphatidylserine on the Cognitive Function

N/A

Completed

NCT05803083 - The Effect of Oral Hyaluronic Acid on the Skin

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05683327
Study type	Interventional
Source	Orthomedico Inc.
Contact
Status	Completed
Phase	N/A
Start date	January 6, 2023
Completion date	June 24, 2023

The Effect of Oral Hyaluronic Acid (UltraHA®) on the Knee Function

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms